Amgen Long Term Debt 2006-2020 | AMGN

Amgen long term debt from 2006 to 2020. Long term debt can be defined as the sum of all long term debt fields.
  • Amgen long term debt for the quarter ending March 31, 2020 was $30.008B, a 2.35% increase year-over-year.
  • Amgen long term debt for 2019 was $26.95B, a 8.68% decline from 2018.
  • Amgen long term debt for 2018 was $29.51B, a 13.69% decline from 2017.
  • Amgen long term debt for 2017 was $34.19B, a 13.24% increase from 2016.
Amgen Annual Long Term Debt
(Millions of US $)
2019 $26,950
2018 $29,510
2017 $34,190
2016 $30,193
2015 $29,182
2014 $30,215
2013 $29,623
2012 $24,034
2011 $21,344
2010 $10,874
2009 $4,512
2008 $4,257
2007 $5,080
2006 $5,080
2005 $1,759
Amgen Quarterly Long Term Debt
(Millions of US $)
2020-03-31 $30,008
2019-12-31 $26,950
2019-09-30 $27,742
2019-06-30 $27,798
2019-03-31 $29,319
2018-12-31 $29,510
2018-09-30 $29,350
2018-06-30 $30,209
2018-03-31 $33,358
2017-12-31 $34,190
2017-09-30 $33,777
2017-06-30 $33,603
2017-03-31 $30,293
2016-12-31 $30,193
2016-09-30 $30,526
2016-06-30 $27,928
2016-03-31 $32,060
2015-12-31 $29,182
2015-09-30 $30,511
2015-06-30 $30,702
2015-03-31 $29,841
2014-12-31 $30,215
2014-09-30 $30,480
2014-06-30 $30,828
2014-03-31 $29,519
2013-12-31 $29,623
2013-09-30 $27,178
2013-06-30 $23,908
2013-03-31 $23,885
2012-12-31 $24,034
2012-09-30 $24,020
2012-06-30 $21,962
2012-03-31 $19,028
2011-12-31 $21,344
2011-09-30 $13,881
2011-06-30 $2,279
2011-03-31 $2,246
2010-12-31 $10,874
2010-09-30 $2,263
2010-06-30 $2,232
2010-03-31 $2,201
2009-12-31 $4,512
2009-09-30 $4,447
2009-06-30 $4,383
2009-03-31 $4,320
2008-12-31 $4,257
2008-09-30 $10,176
2008-06-30 $5,081
2008-03-31 $5,080
2007-12-31 $5,080
2007-09-30 $5,080
2007-06-30 $5,080
2007-03-31 $5,080
2006-12-31 $5,080
2006-09-30 $5,000
2006-06-30 $5,000
2006-03-31 $5,000
2005-12-31 $1,759
2005-09-30
2005-06-30
2005-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $138.744B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $96.511B 12.51
CSL (CSLLY) Australia $90.660B 0.00
Vertex Pharmaceuticals (VRTX) United States $75.271B 51.75
Regeneron Pharmaceuticals (REGN) United States $68.613B 26.45
Illumina (ILMN) United States $54.441B 55.94
Biogen (BIIB) United States $43.661B 7.47
Seattle Genetics (SGEN) United States $29.413B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.786B 10.65
Moderna (MRNA) United States $23.836B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
Incyte (INCY) United States $22.600B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.304B 202.20
Genmab (GMAB) Denmark $22.123B 18.22
Genmab (GNMSF) Denmark $20.669B 61.36
Alnylam Pharmaceuticals (ALNY) United States $17.086B 0.00
BioNTech SE (BNTX) Germany $15.101B 0.00
BeiGene (BGNE) Cayman Islands $14.571B 0.00
Exact Sciences (EXAS) United States $13.034B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.873B 37.87
Sarepta Therapeutics (SRPT) United States $12.505B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.603B 26.09
ARGENX SE-ADR (ARGX) Netherlands $10.588B 0.00
Bio-Techne Corp (TECH) United States $10.094B 66.68
QIAGEN (QGEN) Netherlands $9.750B 28.35
Immunomedics (IMMU) United States $8.183B 0.00
Guardant Health (GH) United States $7.673B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.555B 0.00
Exelixis (EXEL) United States $7.280B 25.53
Ascendis Pharma (ASND) Denmark $7.097B 0.00
Repligen (RGEN) United States $6.466B 113.40
Adaptive Biotechnologies (ADPT) United States $6.139B 0.00
Reata Pharmaceuticals (RETA) United States $5.186B 0.00
Acceleron Pharma (XLRN) United States $5.128B 0.00
Mirati Therapeutics (MRTX) United States $4.983B 0.00
Novavax (NVAX) United States $4.831B 0.00
Vir Biotechnology (VIR) United States $4.830B 0.00
Zai Lab (ZLAB) China $4.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.666B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.554B 97.99
MyoKardia (MYOK) United States $4.510B 0.00
Inovio Pharmaceuticals (INO) United States $4.261B 0.00
Blueprint Medicines (BPMC) United States $4.227B 0.00
MorphoSys AG (MOR) Germany $4.167B 32.32
Emergent Biosolutions (EBS) United States $4.146B 27.17
China Biologic Products (CBPO) China $4.022B 22.36
Momenta Pharmaceuticals (MNTA) United States $3.916B 0.00
Amicus Therapeutics (FOLD) United States $3.886B 0.00
Global Blood Therapeutics (GBT) United States $3.847B 0.00
Halozyme Therapeutics (HALO) United States $3.641B 0.00
Bluebird Bio (BLUE) United States $3.397B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.336B 0.00
NeoGenomics (NEO) United States $3.263B 238.31
Arena Pharmaceuticals (ARNA) United States $3.169B 0.00
Alkermes (ALKS) Ireland $3.080B 60.64
Insmed (INSM) United States $2.783B 0.00
Amarin (AMRN) Ireland $2.668B 0.00
Fate Therapeutics (FATE) United States $2.666B 0.00
Denali Therapeutics (DNLI) United States $2.554B 0.00
Viela Bio (VIE) United States $2.209B 0.00
UniQure (QURE) Netherlands $1.997B 0.00
Principia Biopharma (PRNB) United States $1.976B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
Alector (ALEC) United States $1.932B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.877B 0.00
Twist Bioscience (TWST) United States $1.856B 0.00
Eidos Therapeutics (EIDX) United States $1.837B 0.00
Ligand Pharmaceuticals (LGND) United States $1.795B 69.91
I-Mab (IMAB) China $1.708B 0.00
Intra-Cellular Therapies (ITCI) United States $1.706B 0.00
Adverum Biotechnologies (ADVM) United States $1.677B 0.00
Zymeworks (ZYME) Canada $1.643B 0.00
Editas Medicine (EDIT) United States $1.634B 0.00
Epizyme (EPZM) United States $1.623B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.578B 0.00
Mersana Therapeutics (MRSN) United States $1.567B 0.00
Beam Therapeutics (BEAM) United States $1.442B 0.00
Cytokineticsorporated (CYTK) United States $1.402B 0.00
Revance Therapeutics (RVNC) United States $1.393B 0.00
Zealand Pharma (ZEAL) Denmark $1.391B 0.00
Akcea Therapeutics (AKCA) United States $1.385B 0.00
REGENXBIO (RGNX) United States $1.372B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.345B 0.00
Mesoblast (MESO) Australia $1.327B 0.00
Sorrento Therapeutics (SRNE) United States $1.317B 0.00
Arvinas (ARVN) United States $1.313B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.302B 0.00
Coherus BioSciences (CHRS) United States $1.267B 8.84
Sangamo Therapeutics (SGMO) United States $1.262B 0.00
NantKwest (NK) United States $1.210B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Athenex (ATNX) United States $1.123B 0.00
Intellia Therapeutics (NTLA) United States $1.080B 0.00
Compugen (CGEN) Israel $1.028B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.964B 0.00
Alcobra (ARCT) United States $0.930B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Heska (HSKA) United States $0.875B 0.00
Intrexon (PGEN) United States $0.859B 0.00
Myriad Genetics (MYGN) United States $0.845B 43.62
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Morphic Holding (MORF) United States $0.828B 0.00
Kadmon Holdings (KDMN) United States $0.819B 0.00
Dynavax Technologies (DVAX) United States $0.818B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Cara Therapeutics (CARA) United States $0.800B 0.00
Cellectis S.A (CLLS) France $0.756B 0.00
Frequency Therapeutics (FREQ) United States $0.721B 0.00
VBI Vaccines (VBIV) United States $0.715B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.703B 0.00
Cue Biopharma (CUE) United States $0.697B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.679B 0.00
Codexis (CDXS) United States $0.673B 0.00
Agenus (AGEN) United States $0.658B 0.00
Castle Biosciences (CSTL) United States $0.649B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Aquinox Pharmaceuticals (NLTX) United States $0.637B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.624B 5.35
Vericel (VCEL) United States $0.623B 115.17
Bellus Health (BLU) Canada $0.621B 0.00
AnaptysBio (ANAB) United States $0.609B 0.00
MiMedx (MDXG) United States $0.597B 0.00
NextCure (NXTC) United States $0.590B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.584B 0.00
Kala Pharmaceuticals (KALA) United States $0.574B 0.00
Cel-Sci (CVM) United States $0.562B 0.00
UROGEN PHARMA (URGN) United States $0.546B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Scholar Rock Holding (SRRK) United States $0.544B 0.00
Athersys (ATHX) United States $0.542B 0.00
Anika Therapeutics (ANIK) United States $0.536B 17.23
Syndax Pharmaceuticals (SNDX) United States $0.535B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
Protagonist Therapeutics (PTGX) United States $0.485B 0.00
DBV Technologies S.A (DBVT) France $0.482B 0.00
MeiraGTx Holdings (MGTX) United States $0.468B 0.00
Merus (MRUS) Netherlands $0.467B 0.00
AC Immune SA (ACIU) Switzerland $0.455B 0.00
Geron (GERN) United States $0.443B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.439B 0.00
BioDelivery Sciences (BDSI) United States $0.437B 22.95
Precision BioSciences (DTIL) United States $0.432B 0.00
Prothena (PRTA) Ireland $0.417B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
Albireo Pharma (ALBO) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.392B 7.76
CytomX Therapeutics (CTMX) United States $0.383B 0.00
MannKind (MNKD) United States $0.373B 0.00
WAVE Life Sciences (WVE) Singapore $0.372B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Affimed (AFMD) Germany $0.352B 0.00
OSMOTICA PHARM (OSMT) United States $0.347B 0.00
Seres Therapeutics (MCRB) United States $0.346B 0.00
Kamada (KMDA) Israel $0.345B 14.37
PDL BioPharma (PDLI) United States $0.339B 291.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
Celldex Therapeutics (CLDX) United States $0.293B 0.00
Cellular Biomedicine (CBMG) United States $0.290B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Pfenex (PFNX) United States $0.286B 0.00
ChromaDex (CDXC) United States $0.282B 0.00
Verastem (VSTM) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.279B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.279B 0.00
IBio (IBIO) United States $0.263B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.262B 0.00
IVERIC Bio (ISEE) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Prometic Life Sciences (LMNL) Canada $0.253B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.253B 0.00
Selecta Biosciences (SELB) United States $0.248B 0.00
Gritstone Oncology (GRTS) United States $0.247B 0.00
Northwest Biotherapeutics (NWBO) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
Dyadic (DYAI) United States $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
Fortress Biotech (FBIO) United States $0.221B 0.00
Pluristem Therapeutics (PSTI) Israel $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.213B 3.22
Exicure (XCUR) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
Strongbridge Biopharma (SBBP) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.202B 0.00
Aptinyx (APTX) United States $0.190B 0.00
Aduro Biotech (ADRO) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.186B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
Aytu Bioscience (AYTU) United States $0.171B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
Cyclerion Therapeutics (CYCN) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Trevena (TRVN) United States $0.161B 0.00
VolitionRX (VNRX) United States $0.160B 0.00
Cerecor (CERC) United States $0.155B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Cidara Therapeutics (CDTX) United States $0.152B 0.00
Celyad SA (CYAD) Belgium $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
TELA Bio (TELA) United States $0.148B 0.00
Applied Genetic Technologies (AGTC) United States $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
Orgenesis (ORGS) United States $0.134B 0.00
PHASEBIO PHARMA (PHAS) United States $0.132B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.126B 0.00
Protalix BioTherapeutics (PLX) Israel $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Celsion (CLSN) United States $0.119B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Palatin Technologies (PTN) United States $0.117B 3.01
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Eton Pharmaceuticals (ETON) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.109B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
AquaBounty Technologies (AQB) United States $0.103B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.092B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 0.00
Organovo Holdings (ONVO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Spherix (AIKI) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Novogen (KZIA) Australia $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
BioCardia (BCDA) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00